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Abstract
Background: Drug therapy is recommended in conjunction with surgery in treatment of actinomycetoma. The
specific prescription depends on the type of bacteria (actinomycetoma) or fungi (eumycetoma) causing the disease
and their in vitro antimicrobial susceptibility.
Objectives: To investigate the antimicrobial susceptibility among isolates of Streptomyces spp. isolated from cases
of actinomycetoma in man and animals in Sudan.
Methods: Streptomyces strains (n = 18) isolated from cases of actinomycetoma were tested in vitro against
15 commonly prescribed antibacterial agents using MIC agar dilution method as per standard guidelines.
Results: Streptomyces strains isolated from actinomycetoma fall into various phenotypic groups. All of the strains
were inhibited by novobiocin (8 μg/mL), gentamycin (8, 32 μg/mL) and doxycycline (32 μg/mL). Fusidic acid
(64 μg/mL) inhibited 94.4% of the strains; bacitracin, streptomycin, cephaloridine, clindamycin, ampicillin, rifampicin
and tetracycline (64 μg/mL) inhibited between 61.1 and 77.8% of the strains. All strains were found resistant to
amphotericin B (64 μg/mL), penicillin (20 μg/mL) and sulphamethoxazole (64 μg/mL).
Conclusions: Saprophytic Streptomyces spp. cause actinomycetoma in man and animal belong to separate
phenotypes and have a wide range of susceptibility patterns to antimicrobial agents, which pose a lot of
difficulties in selecting effective in vivo treatment for actinomycetoma.
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Background
Actinomycetoma is a slowly progressive, destructive
infection of the cutaneous and subcutaneous tissues, fas-
cia, and bones, caused by fungi (eumycetoma) or by
aerobic actinomycete bacteria (actinomycetoma or acti-
nomycotic mycetoma) and mainly prevalent in tropical
countries [1]. The major agents of aerobic actinomycetes
are: Nocardia brasiliensis, Actinomadura madurae and
Streptomyces somaliensis [2,3]. Strep. sudanensis has
recently being described as one of the etiological agents
of actinomycetoma [4]. Actinomycetoma is a major
health problem in parts of Sudan [5-8].
Diagnosis of mycetoma relies on direct examination of
grains and isolation of the etiologic agents. The discharging
grains represent aggregates of bacterial filaments or fun-
gal hyphae. The salient features of the grains may assist
in the clinical diagnosis: eumycetomas due to Madurella
spp. typically produce black grains; actinomycetomas
never produce dark grains, and usually are yellow to
orange; and those caused by Actinomadurae pelletieri are
red to pink [3,7,9]. Analysis of mycetoma sampled for
further histological processing provides some clues to the
potential microorganism, but culture is the gold standard
for diagnosis [10].
It seems likely that patients who do not respond to
standard therapeutic treatment may be infected with
unknown actinomycetes and thereby requires specific
antibiotic treatment regimes [11]. This is a serious pro-
blem as actinomycetoma becomes dangerous to health,
or even life, when treatment is inadequate or delayed. A
thorough microbiological diagnosis while desirable is
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characterizing the causal agents.
The aim of this study was to investigate the suscept-
ibility of various phenotypes of streptomycetes isolated
from cases of actinomycetoma in human (madura foot)
and donkeys (fistulus wihters) in Sudan.
Materials and methods
Strains
The present study perform antimicrobial sensitivity testing
on Streptomyces strains (n = 18) isolated from cases of
actinomycetoma in human (madura foot) and actinomyce-
toma in donkeys (fistulus wihters) between 1998 and 2003
in Khartoum State, Sudan. The 18 Streptomyces strains are
labeled as SD551, SD552, SD559, SD572, SD573, SD575,
SD576 (donkey isolates) and S. somaliensis DSM 40738
T,
S. sudanensis DSM 41923
T, SD509, DSM41607,
DSM41608, DSM41609, Streptomyces spp.: SD511,
SD524, SD528, SD534 and DSM40760 (human isolates).
S. somaliensis DSM 40738
T and S. sudanensis DSM
41923
T served as controls. Details of strains and isola-
tion methods have been described previously [4,12]. The
strains were sub cultured from frozen 20% glycerol
stocks on Tryptic Soy agar plates (TSA; Difco). The
inoculated plates were incubated aerobically at 37°C for
up to seven days.
Identification scheme
Isolates were tentatively identified as member of the
genus Streptomyces on the basis of selected phenotypic
criteria [13]. The cultural and microscopic features of
the genus Streptomyces are: aerobic growth, gram-posi-
tive, non-acid-alcohol-fast, non-motile actinomycete
which forms extensively branched, light yellow substrate
mycelia on a variety of media with or without aerial
hyphae, with or without diffusible pigments on the
media. In the present study phenotypic clusters of iso-
lates were identified mainly on colony color and pre-
sence of diffusible pigments (Figure 1).
Antimicrobial Susceptibility Tests
Streptomyces isolates (n = 18) including clinical isolates
and type strains of S. somaliensis DSM 40738
T, S. suda-
nensis DSM 41923
T (Table 1) were tested for their abil-
ity to grow in TSA supplemented with antibiotics or
antimicrobial agents using the minimum inhibitory con-
centration (MIC) agar dilution method. These were per-
formed according to standard methods [14]. A
homogeneous bacterial suspension giving an inoculum
of 10
6-10
8 CFU/mL was prepared by dissolving 1-3
colonies in sterile 2 mL normal saline. The suspension
was used to inoculate each TSA plates containing the
antimicrobial agents and control plates (without drugs)
using a Steer’s replicator.
A total of 15 antimicrobial agents (Table 1) in twofold
to threefold dilution series from 4 to 64 μg/mL making
up a total of 25 concentrations were used. The range is
within the values recommended by the NCCLS [14].
The test and control agar plates were incubated aerobi-
cally at 30°C, for 48-72 h. After incubation, the organ-
isms were classified as sensitive (S) or resistant (R)
according to guidelines [14].
Results
The identification of isolates to cluster and phenotypic
groups was done according to microscopic and growth
characteristics. The isolates exhibited different phenoty-
pic features (Figure 1). Figure 1 showed examples of col-
ony morphology variations which ranged from grey to
blue to grey brown or grey white colonies. The full
identification of the isolates is under studies to establish
their taxonomic positions.
The results of antimicrobial susceptibility testing are
shown in Table 1 and Figure 2. Three agents: novobio-
cin (8 μg/mL), gentamycin sulphate (8, 32 μg/mL) and
doxycycline hydrochloride (32 μg/mL) inhibited all
strains. Fusidic acid (64 μg/mL) inhibited 94.4% of the
strains; bacitracin (16 μg/mL) inhibited 77.8% of the
strains; streptomycin sulphate (8 μg/mL) and cephalori-
dine HCl (32 μg/mL) inhibited 66.7% of the strains; clin-
damycin HCl (8 μg/mL); ampicillin HCl (32 μg/mL);
rifampicin (32 μg/mL) and tetracycline HCl (64 μg/mL)
inhibited 61.1% of the strains.
Other antibacterial agents revealed results ranging
from 0 to 85%. All strains were found resistant to
amphotericin B (64 μg/mL), penicillin (20 μg/mL) and
sulphamethoxazole (64 μg/mL) (Table 1; Figure 2).
Discussion
Regular surveillance of hospital-associated actinomyce-
toma infections and monitoring of antibiotic sensitivity
pattern is required to prompt the treatment alone or in
conjunction with surgery to reduce chance of amputa-
tion and prolong patient hospitalization due to actino-
mycetoma. Uses of antibiotic sensitivity testing helps to
guide physicians in choosing antibiotics, but our find-
ings indicated that large, seemingly unlimited numbers
of saprophytic Streptomyces, potentially new species,
exhibited various antimicrobial profiles. In the present
study 13 phenotypic groups become apparent out of 18
clinical isolates and showed 15 different antibacterial
susceptibility profiles. The accumulated sensitivity
results on different pathogens guide physicians in choos-
ing empirical treatment in serious patients before the
individual’s laboratory results are analyzed in the micro-
biology laboratory. In the present study four antibiotics
(novobiocin, gentamycin, doxycycline and fusidic acid)
inhibited more than 90% of the strains, which could be
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ment of actinomycetoma. Even though, a combination
of sulphamethoxazole and trimethoprim is commonly
used as treatment worldwide [15]. Currently the com-
mon drugs regimes practiced in Sudan for the treatment
of actinomycetoma are amikacin in combination with
co-trimoxazole and in resistant cases other drugs such
as streptomycin combined with co-trimoxazole or strep-
tomycin combined with rifampicin are practiced [16].
Nasher et al. [17] reported that rifampicin was the
most effective antibiotic against S. somaliensis strains
isolated from Sudanese patients, followed by erythromy-
cin, tobramycin, fusidic acid and streptomycin sulphate.
In contrast they found that S. somaliensis strains were
all resistant to trimethoprim. The present study empha-
s i z e dt h a ti s o l a t e sf r o mS u d a n e s ep a t i e n t sa r en o ta l lS.
somaliensis, instead S. sudanensis, and other unidentified
isolates are causal agents with different antimicrobial
profiles. The two studies applied different methods and
the species analyzed in Nasher et al. [17] study might
have included strains other than S. somaliensis. Never-
theless, the findings in the present study found that the
majority of the strains were sensitive to fusidic acid.
Kelly et al. [18] documented an excellent correlation
when four methods for testing the antibacterial, includ-
ing the agar dilution method which has been adopted in
Figure 1 Streptomyces spp. exhibiting different phenotypic features: A, Streptomyces sp. SD575; B, Streptomyces sp. SD579; C,
Streptomyces sp. SD573 and D, Streptomyces sp. SD534.
Hamid Annals of Clinical Microbiology and Antimicrobials 2011, 10:24
http://www.ann-clinmicrob.com/content/10/1/24
Page 3 of 5their study [18]. The method was found suitable for
testing strains of Streptomyces and other clinically signif-
icant aerobic actinomycetes. Application of genotypic
and phenotypic analysis enables description of many
novel species. These are in addition to S. somaliensis,
the classic known cause of actinomycetoma in human.
The slow and often filamentous growth of actinomycetes
does not allow sufficient standardization of both the
agar dilution and broth dilution method [13]. Knowl-
e d g eo nt h ea n t i b i o t i cs u s c e p t i b i l i t yo fp a t h o g e n i ca c t i -
nomycetes is considered a challenge. This is why the
chemotherapy of diseases caused by actinomycetes may
still present problems. Complete and reliable data on
the in vitro sensitivity of these pathogens can be
obtained, however, when standardized and specially
adapted methods of susceptibility testing are employed
[19]. Special adaptations should cover the general
technique of in vitro testing, as well as the choice of test
media, the preparation of inocula, incubation methods
and method of reading results. Provided that all factors
are taken into account which might cause difficulties in
test reproducibility and therapeutic relevance of the
results, in vitro tests appear to contribute to the revision
and updating of treatment regimes for many infections
including human actinomycosis [19].
Conclusions
Streptomyces spp. from cases actinomycetoma in man
and animals are phenotypically diverse and have wide
range of susceptibility patterns to antimicrobial agents.
This causes a lot of difficulties in selecting effective in
vivo treatment for actinomycetoma in man and animals.
Studies are underway in Sudan, UK, Poland and Mexico
to complete the genotypic characterization of all
Table 1 The results of antimicrobial susceptibility of 18 strains of Streptomyces to 15 antimicrobial agents (25 total
folds)
Strain*
Resistance to antimicrobial agents (μg ml-1):
1234566891 01 11 21 31 41 51 61 71 8
Amphotericin B (16) R R R RRRRRRR R R R R R R R R
Amphotericin B (32) R R R RRRRRRR R R R R R R R R
Amphotericin B (64) R R R RRRRRRR R R R R R R R R
Ampicillin hydrochloride (8) R R R RRRRRRR R R R S R S R R
Ampicillin hydrochloride (32) R R R R S S R S S S S S S S R S S R
Amoxicillin (32) R R R R R S RRRR R R R S R S R R
Amoxicillin (64) R R R RRRRRRR R R R R R S R R
Bacitracin (16) S S R SSSRSSS S S S R S S S R
Cephaloridine hydrochloride (32) R R R SSSRSSS S S S S R S S R
Clindamycin hydrochloride (8) R R R R S S R S S S S S S S R S S R
Doxycycline hydrochloride (16) S R R SSSSSSS S S S S S S S R
Doxycycline hydrochloride (32) s s S sssSSSS S S S S S S S S
Fusidic acid (32) S R R SSSRSSS S S S S S S S S
Fusidic acid (64) s s R sssSSSS S S S S S S S S
Gentamycin sulphate (8) S S S SSSRSSS S S S S S S S S
Gentamycin sulphate (32) s s S sssSSSS S S S S S S S S
Novobiocin (4) S R R SSSSSSS S S S S S S S S
Novobiocin (8) s s S sssSSSS S S S S S S S S
Rifampicin (32) R R R SSSRSSS S S S R S S R R
Penicillin G (10) R R R RRRRRRR R R R R R R R R
Penicillin G (20) R R R RRRRRRR R R R R R R R R
Streptomycin sulphate (8) S R R R SSSSSS S S S R R S S R
Sulphamethoxazole (32) R R R RRRRRRR R R R R R R R R
sulphamethoxazole (64) R R R RRRRRRR R R R R R S R R
Tetracycline hydrochloride (64) R R R R S S R S S S S S R S S S S R
Abbreviations: S, sensitive, R, resistant.
* Strains: 1, Streptomyces sp. SD551; 2, Streptomyces sp. SD552; 3, Streptomyces sp. SD559; 4, Streptomyces sp. SD572; 5, Streptomyces sp. SD573; 6, Streptomyces sp.
SD575; 7, Streptomyces sp. SD576; 8, S. sudanensis DSM41923
T;9 ,S. sudanensis SD509; 10, S. sudanensis DSM41607; 11, S. sudanensis DSM41608; 12, S. sudanensis
DSM41609; 13, S. somaliensis DSM40738
T; 14, Streptomyces sp. SD 511; 15, Streptomyces sp. SD534; 16, Streptomyces sp. SD528; 17, Streptomyces sp. SD524; 18,
Streptomyces sp. DSM40760.
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cases in Sudan so far.
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Figure 2 Susceptibility of different Streptomyces spp. causing actinomycetoma to various antimicrobial agents.
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